125 related articles for article (PubMed ID: 7658164)
21. Structural and functional properties of apolipoprotein B in chemically modified low density lipoproteins.
Vanderyse L; Devreese AM; Baert J; Vanloo B; Lins L; Ruysschaert JM; Rosseneu M
Atherosclerosis; 1992 Dec; 97(2-3):187-99. PubMed ID: 1466663
[TBL] [Abstract][Full Text] [Related]
22. Structural requirements for the binding of modified proteins to the scavenger receptor of macrophages.
Zhang H; Yang Y; Steinbrecher UP
J Biol Chem; 1993 Mar; 268(8):5535-42. PubMed ID: 8383674
[TBL] [Abstract][Full Text] [Related]
23. Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor.
Parthasarathy S; Fong LG; Otero D; Steinberg D
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):537-40. PubMed ID: 3467373
[TBL] [Abstract][Full Text] [Related]
24. Moderate oxidation of hypertriglyceridemic low-density lipoprotein causes apolipoprotein B epitope change and enhances its uptake by macrophages.
Ishikawa Y; Inadera H; Shirai K; Hashimoto H; Fukamachi I; Saito Y; Yoshida S
Biochim Biophys Acta; 1992 Jun; 1126(1):60-4. PubMed ID: 1376622
[TBL] [Abstract][Full Text] [Related]
25. Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor.
Podrez EA; Hoppe G; O'Neil J; Hoff HF
Free Radic Biol Med; 2003 Feb; 34(3):356-64. PubMed ID: 12543251
[TBL] [Abstract][Full Text] [Related]
26. Modulation of the expression of human LDL-Apo B-100 epitopes by lipids and apolipoproteins.
Harduin P; Tailleux A; Fruchart JC; Fievet C
Arterioscler Thromb; 1993 Apr; 13(4):529-35. PubMed ID: 7682107
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.
Flood C; Gustafsson M; Pitas RE; Arnaboldi L; Walzem RL; Borén J
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):564-70. PubMed ID: 14726411
[TBL] [Abstract][Full Text] [Related]
28. Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100.
Parthasarathy S; Barnett J
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9741-5. PubMed ID: 2263624
[TBL] [Abstract][Full Text] [Related]
29. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.
Goldberg IJ; Wagner WD; Pang L; Paka L; Curtiss LK; DeLozier JA; Shelness GS; Young CS; Pillarisetti S
J Biol Chem; 1998 Dec; 273(52):35355-61. PubMed ID: 9857078
[TBL] [Abstract][Full Text] [Related]
30. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex.
Cathcart MK; McNally AK; Chisolm GM
J Lipid Res; 1991 Jan; 32(1):63-70. PubMed ID: 1901344
[TBL] [Abstract][Full Text] [Related]
31. Expression of apolipoprotein B epitopes in low density lipoproteins of hemodialyzed patients.
Reade V; Tailleux A; Reade R; Harduin P; Cachera C; Tacquet A; Fruchart JC; Fievet C
Kidney Int; 1993 Dec; 44(6):1360-5. PubMed ID: 7508006
[TBL] [Abstract][Full Text] [Related]
32. The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells.
Aviram M; Lund-Katz S; Phillips MC; Chait A
J Biol Chem; 1988 Nov; 263(32):16842-8. PubMed ID: 3182816
[TBL] [Abstract][Full Text] [Related]
33. Effect of lipid transfer activity and triglyceride hydrolysis on apolipoprotein B immunoreactivity in modified low density lipoproteins.
Viens L; Lagrost L
J Lipid Res; 1997 Jun; 38(6):1129-38. PubMed ID: 9215541
[TBL] [Abstract][Full Text] [Related]
34. Immunological properties of apoB-containing lipoprotein particles in human atherosclerotic arteries.
Tailleux A; Torpier G; Caron B; Fruchart JC; Fievet C
J Lipid Res; 1993 May; 34(5):719-28. PubMed ID: 7685370
[TBL] [Abstract][Full Text] [Related]
35. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
Krul ES; Tikkanen MJ; Cole TG; Davie JM; Schonfeld G
J Clin Invest; 1985 Feb; 75(2):361-9. PubMed ID: 3973009
[TBL] [Abstract][Full Text] [Related]
36. Cellular oxidative modification of low density lipoprotein does not require lipoxygenases.
Sparrow CP; Olszewski J
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):128-31. PubMed ID: 1729678
[TBL] [Abstract][Full Text] [Related]
37. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
[TBL] [Abstract][Full Text] [Related]
38. The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein B.
Zawadzki Z; Tercé F; Seman LJ; Theolis RT; Breckenridge WC; Milne RW; Marcel YL
Biochemistry; 1988 Nov; 27(22):8474-81. PubMed ID: 2468359
[TBL] [Abstract][Full Text] [Related]
39. A modification of apolipoprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein.
Martens JS; Lougheed M; Gómez-Muñoz A; Steinbrecher UP
J Biol Chem; 1999 Apr; 274(16):10903-10. PubMed ID: 10196168
[TBL] [Abstract][Full Text] [Related]
40. Higher reactivity of apolipoprotein B-100 and alpha-tocopherol compared to sialic acid moiety of low-density lipoprotein (LDL) in radical reaction.
Matsukawa N; Nariyama Y; Hashimoto R; Kojo S
Bioorg Med Chem; 2003 Sep; 11(18):4009-13. PubMed ID: 12927863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
